Malignant histiocytosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Malignant histiocytosis Classification and external resources | |
| ICD-10 | C96.1 |
|---|---|
| ICD-9 | 202.3 |
| ICD-O: | 9750/3 |
| MeSH | D006647 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Malignant histiocytosis is a hereditary disease found in the Bernese Mountain Dog characterized by histiocytic infiltration of the lungs and lymph nodes. The liver, spleen, and central nervous system can also be affected. Histiocytes are a component of the immune system that proliferate abnormally in this disease. In addition to its importance in veterinary medicine, the condition is also important in human pathology.[1]
Histiocytic disorders
A histiocyte is a differentiated tissue cell that has its origin in the bone marrow. The source for histiocytes is the monocyte/macrophage line. Monocytes (found in the blood) and macrophages (found in tissue) are responsible for phagocytosis (ingestion) of foreign material in the body. Langerhans cells are dendritic cells found in the skin and function by internalizing antigens (foreign particles) and presenting them to T cells. They arise from monocytes.[1] Histiocytic disorders refer to diseases that are caused by abnormal behavior of these cells. They include the following:
- Reactive diseases of Langerhans cells
- Histiocytomas
- Cutaneous histiocytosis
- Systemic histiocytosis
- Reactive diseases of macrophages
- Hemophagocytic syndrome - a condition where macrophages phagocytose myeloid and erythroid precursors (similar to hemophagocytic lymphohistiocytosis in humans)
- Malignant diseases of Langerhans dells
- Malignant histiocytosis
- Diffuse histiocytic sarcoma
- Localized histiocytic sarcoma
- Malignant diseases of macrophages
- Histiocytic lymphoma
Breed disposition
Up to 25 percent of Bernese Mountain Dogs may develop malignant histiocytosis in their lifetime.[1] Other breeds with a possible genetic tendency toward malignant histiocytosis include Rottweilers, Flat-Coated Retrievers, and Golden Retrievers[1].
Signs and symptoms
The disease in the lungs is characterized by enlargement of the tracheobronchial lymph nodes and infiltration of the lungs, sometimes leading to lung lobe consolidation and pleural effusion.[1] Signs and symptoms include cough, loss of appetite, weight loss, anemia, and difficulty breathing.[1] Seizures and rear limb weakness can be seen. Invasion of the bone marrow can cause pancytopenia.[1] Diagnosis requires a biopsy.
Treatment
Treatment with chemotherapy has been used with some success, particularly using lomustine, prednisone, doxorubicin, and cyclophosphamide.[1] Because of the rapid progression of this aggressive disease, the prognosis is very poor.[1]
Other histiocytic diseases in Bernese Mountain Dogs
A similar disease is diffuse histiocytic sarcoma, a term used to designate a localized histiocytic sarcoma that has spread throughout the body.[1]
Another disease of histiocytic origin that affects Bernese Mountain Dogs is systemic histiocytosis. This condition generally begins as lesions on the eyelids, nasal mucosa, and skin, especially the scrotum. It progresses to a more generalized disease affecting the lymph nodes, bone marrow and spleen.[1] Other signs and symptoms include weight loss and loss of appetite.[1] It also has a very poor prognosis.
See also
References
External links
- Berner-Garde Foundation
- School of Veterinary Medicine Canine Histiocytosis Site at University of California, Davis
- Berner-Garde Foundation Articles on Malignant Histiocytosis
- Histiocytoma and Histiocytic Sarcoma in Cats and Dogs from Pet Cancer Center
- Stories of Malignant Histiocytosis victims
WikiDoc Research Resources for Malignant histiocytosis (Click show to right to view) | |
|---|---|
| Articles on Malignant histiocytosis | Most recent articles on Malignant histiocytosis • Most cited articles on Malignant histiocytosis • Review articles on Malignant histiocytosis • Articles on Malignant histiocytosis in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Malignant histiocytosis | Powerpoint slides on Malignant histiocytosis • Images of Malignant histiocytosis • Photos of Malignant histiocytosis • Podcasts & MP3s on Malignant histiocytosis • Videos on Malignant histiocytosis |
| Evidence Based Medicine Regarding Malignant histiocytosis | Cochrane Collaboration on Malignant histiocytosis • Bandolier on Malignant histiocytosis • TRIP on Malignant histiocytosis |
| Cost Effectiveness of Malignant histiocytosis | Cost Effectiveness of Malignant histiocytosis |
| Clinical Trials Involving Malignant histiocytosis | Ongoing Trials on Malignant histiocytosis at Clinical Trials.gov • Trial results on Malignant histiocytosis • Clinical Trials on Malignant histiocytosis at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Malignant histiocytosis | US National Guidelines Clearinghouse on Malignant histiocytosis • NICE Guidance on Malignant histiocytosis • NHS PRODIGY Guidance • FDA on Malignant histiocytosis • CDC on Malignant histiocytosis |
| Textbook Information on Malignant histiocytosis | Books and Textbook Information on Malignant histiocytosis |
| Pharmacology Resources on Malignant histiocytosis | Dosing of Malignant histiocytosis • Drug interactions with Malignant histiocytosis • Side effects of Malignant histiocytosis • Allergic reactions to Malignant histiocytosis • Overdose information on Malignant histiocytosis • Carcinogenicity information on Malignant histiocytosis • Malignant histiocytosis in pregnancy • Pharmacokinetics of Malignant histiocytosis • |
| Genetics, Pharmacogenomics, and Proteinomics of Malignant histiocytosis | Genetics of Malignant histiocytosis • Pharmacogenomics of Malignant histiocytosis • Proteomics of Malignant histiocytosis |
| Newstories on Malignant histiocytosis | Malignant histiocytosis in the news • Be alerted to news on Malignant histiocytosis • News trends on Malignant histiocytosis |
| Commentary on Malignant histiocytosis | Blogs on Malignant histiocytosis |
| Patient Resources on Malignant histiocytosis | Patient resources on Malignant histiocytosis • Discussion groups on Malignant histiocytosis • Patient Handouts on Malignant histiocytosis • Directions to Hospitals Treating Malignant histiocytosis • Risk calculators and risk factors for Malignant histiocytosis |
| Healthcare Provider Resources on Malignant histiocytosis | Symptoms of Malignant histiocytosis • Causes & Risk Factors for Malignant histiocytosis • Diagnostic studies for Malignant histiocytosis • Treatment of Malignant histiocytosis |
| Continuing Medical Education (CME) Programs on Malignant histiocytosis | CME Programs on Malignant histiocytosis |
| International Resources on Malignant histiocytosis | Malignant histiocytosis en Espanol • Malignant histiocytosis en Francais |
| Business Resources on Malignant histiocytosis | Malignant histiocytosis in the Marketplace • Patents on Malignant histiocytosis |
| Informatics Resources on Malignant histiocytosis | List of terms related to Malignant histiocytosis |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
